NuVasive (NASDAQ:NUVA) Q2 results ($M): Revenue: 292.1 (+3.7%); product sales: 261.4 (+3.4%).
Net income: 15.0 (+30.4%); non-GAAP net income: 32.8 (+8.3%); EPS: 0.29 (+31.8%); non-GAAP EPS: 0.63 (+8.6%).
Cash flow ops (6 mo.): 93.4 (+21.0%).
2019 guidance: Revenue: $1.14B – 1.16B (unch); EPS: $0.93 – 1.03 from $0.95 – 1.03; non-GAAP EPS: $2.25 – 2.35 from $2.20 – 2.30.
Shares up 7% after hours.
Previously: NuVasive EPS beats by $0.07, beats on revenue (July 30)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.